<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since there is no pathognomonic clinical sign or laboratory test to distinguish <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease from other uveitic entities, the diagnosis must be made based on characteristic ocular and systemic findings in the absence of evidence of other disease that can explain the findings </plain></SENT>
<SENT sid="1" pm="."><plain>Ancillary tests, including ocular and brain imaging studies, are used to assess the severity of intraocular <z:mp ids='MP_0001845'>inflammation</z:mp> and systemic manifestations of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease, to identify <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infections</z:e> and other medical conditions that might worsen with systemic treatment, and to monitor for adverse effects of drugs used </plain></SENT>
<SENT sid="2" pm="."><plain>There are two diagnostic or classification criteria in general use by the <z:hpo ids='HP_0000554'>uveitis</z:hpo> community, one from Japan and one from an international group; both rely on a minimum number and/or combination of clinical findings to identify <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
<SENT sid="3" pm="."><plain>Finally, several grading schemes have been proposed to assess severity of ocular disease and response to treatment </plain></SENT>
</text></document>